Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Discover smart ways to save a significant amount each month. Implement these strategies to enhance your financial stability.
13,412 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...
NVIDIA has built a powerful moat around AI hardware and software. This deep dive explains a compelling growth catalys...
A fresh round of chatter around meta’s layoff rumor coming is rattling investors, with analysts weighing how a potent...
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
SoundHound AI has delivered notable revenue gains, even as its stock retreated. This article breaks down what's drivi...
A major investment advisor just boosted its stake in the Invesco BulletShares 2027 Corporate Bond ETF by about $76 mi...
A big institutional move sent ripples through MercadoLibre as NWI Management dumped a large block of shares. This art...
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
A major tech partnership and improving chip demand helped Intel stock climb sharply on Thursday. This deep dive expla...
Large LINK holders moved millions of tokens to Binance just days before a landmark banking initiative was unveiled, s...
As electricity demand climbs, NuScale Power presents a rare risk reward. This piece lays out one compelling buy reaso...